[1]
Farida Jazuli Usman et al. 2025. Metabolic Reprogramming in Prostate Cancer: Impact of TP53 Gain-of-Function Mutations on Tumor Progression and Therapeutic Vulnerabilities. Achievements and Challenges of Medicine and Medical Science Vol. 13. (Mar. 2025), 146–166. DOI:https://doi.org/10.9734/bpi/acmms/v13/4559.